An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Estradiol hemisuccinate/progesterone (EHS/P4), sold under the brand name Hosterona, is an injectable combination medication of estradiol hemisuccinate (EHS), an estrogen, and progesterone (P4), a progestogen, which is used to induce withdrawal bleeding in women with non-pregnancy-related amenorrhea (absence of menstruation). It is provided in the form of ampoules containing 20 mg/2 mL EHS and 100 mg/2 mL P4 and is administered by intramuscular injection. The medication is available in Argentina and Paraguay.

Property Value
dbo:abstract
  • Estradiol hemisuccinate/progesterone (EHS/P4), sold under the brand name Hosterona, is an injectable combination medication of estradiol hemisuccinate (EHS), an estrogen, and progesterone (P4), a progestogen, which is used to induce withdrawal bleeding in women with non-pregnancy-related amenorrhea (absence of menstruation). It is provided in the form of ampoules containing 20 mg/2 mL EHS and 100 mg/2 mL P4 and is administered by intramuscular injection. The medication is available in Argentina and Paraguay. (en)
dbo:alternativeName
  • Hosterona (en)
dbo:thumbnail
dbo:wikiPageID
  • 60483204 (xsd:integer)
dbo:wikiPageLength
  • 3682 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1100269685 (xsd:integer)
dbo:wikiPageWikiLink
dbp:caption
dbp:class
dbp:component
  • Progesterone (en)
  • Estradiol hemisuccinate (en)
dbp:drugName
  • Estradiol hemisuccinate / (en)
  • progesterone (en)
dbp:image
  • Progesterone.svg (en)
dbp:routesOfAdministration
dbp:synonyms
  • EHS/P4 (en)
dbp:tradename
  • Hosterona (en)
dbp:type
  • combo (en)
dbp:width
  • 215 (xsd:integer)
  • 250 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Estradiol hemisuccinate/progesterone (EHS/P4), sold under the brand name Hosterona, is an injectable combination medication of estradiol hemisuccinate (EHS), an estrogen, and progesterone (P4), a progestogen, which is used to induce withdrawal bleeding in women with non-pregnancy-related amenorrhea (absence of menstruation). It is provided in the form of ampoules containing 20 mg/2 mL EHS and 100 mg/2 mL P4 and is administered by intramuscular injection. The medication is available in Argentina and Paraguay. (en)
rdfs:label
  • Estradiol hemisuccinate/progesterone (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
foaf:name
  • Estradiol hemisuccinate / (en)
  • progesterone (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License